Back
Ionis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
47
IONS
Ionis Pharmaceuticals
Last Price:
46.90
Seasonality Move:
8.92%
Sell
15
ALNY
Alnylam Pharmaceuticals
Last Price:
246.59
Seasonality Move:
6.72%
Sell
47
Ionis Pharmaceuticals (IONS)
is a Sell
Is Ionis Pharmaceuticals a Buy, Sell or Hold?
- The current Ionis Pharmaceuticals [IONS] share price is $46.89. The Score for IONS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- IONS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IONS Stock Price Chart
What is Ionis Pharmaceuticals's stock price today?
-
The Ionis Pharmaceuticals share price today is $46.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $246.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
IONS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 46.07 | Sell |
| Chaikin Money Flow: | -595556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.63 - 48.37) | Sell |
| Bollinger Bands (100): | (39.9 - 48.48) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 39.94 | Sell |
| Chaikin Money Flow: | -378372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (258.04 - 277.96) | Sell |
| Bollinger Bands (100): | (152.5 - 260.08) | Buy |
IONS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.15 | Sell |
| 20-day SMA: | 47.5 | Sell |
| 50-day SMA: | 48 | Sell |
| 200-day SMA: | 45.96 | Buy |
| 8-day EMA: | 47.73 | Sell |
| 20-day EMA: | 47.77 | Sell |
| 50-day EMA: | 47.03 | Sell |
| 200-day EMA: | 45.1 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.46 | Sell |
| 20-day SMA: | 268.49 | Sell |
| 50-day SMA: | 256.91 | Sell |
| 200-day SMA: | 187.09 | Buy |
| 8-day EMA: | 259.34 | Sell |
| 20-day EMA: | 263.1 | Sell |
| 50-day EMA: | 247.85 | Sell |
| 200-day EMA: | 202.56 | Buy |
Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.18 per share, and an increase next year of $0.29 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Ionis Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||